Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “VTV THERAPEUTICS LLC”

50 pharma patents match "VTV THERAPEUTICS LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 50
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 50 pharmaceutical patents matching "VTV THERAPEUTICS LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

50 results for “VTV THERAPEUTICS LLC” · 30,257 patents in full index Clear search

  1. US 12391658

    Sulfoxide and sulfone glucokinase activators and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  2. US 12091407

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  3. US 11974989

    Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

    VTV THERAPEUTICS LLC · Granted May 7, 2024 · Expires May 2, 2044

    granted
  4. US 11970457

    Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine

    VTV THERAPEUTICS LLC · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  5. US 11883383

    Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine

    VTV THERAPEUTICS LLC · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  6. US 11833136

    Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

    VTV THERAPEUTICS LLC · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted
  7. US 11649230

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted May 16, 2023 · Expires May 11, 2043

    granted
  8. US 11524942

    Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine

    VTV THERAPEUTICS LLC · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted
  9. US 11420929

    Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

    VTV THERAPEUTICS LLC · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted
  10. US 11420942

    Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine

    VTV THERAPEUTICS LLC · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted
  11. US 11130753

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted
  12. US 11096946

    Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

    VTV THERAPEUTICS LLC · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  13. US 10980861

    Glucokinase activator compositions for the treatment of diabetes

    VTV THERAPEUTICS LLC · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  14. US 10952993

    Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

    VTV THERAPEUTICS LLC · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  15. US 10947180

    Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

    VTV THERAPEUTICS LLC · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  16. US 10898475

    Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

    VTV THERAPEUTICS LLC · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  17. US 10889580

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  18. US 10588943

    Glucokinase activator compositions for the treatment of diabetes

    VTV THERAPEUTICS LLC · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  19. US 10570126

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  20. US 10568888

    Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  21. US 10471066

    Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

    VTV THERAPEUTICS LLC · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  22. US 10463652

    Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

    VTV THERAPEUTICS LLC · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  23. US 10456406

    Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

    VTV THERAPEUTICS LLC · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  24. US 10391097

    Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted